CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $348,194
- in 1 filing
Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Tousignant Jennifer Chief Legal Officer | Sale | −4,212 | $24.50 | $103K | 0 |
| 2026-08-19 | Tousignant Jennifer Chief Legal Officer | Option exercise | +10,000 | $14.41 | $144K | 10,000 |
| 2026-08-19 | Tousignant Jennifer Chief Legal Officer | Sale | −10,000 | $24.50 | $245K | 0 |
| 2026-08-19 | Tousignant Jennifer Chief Legal Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 114,072 | ||
| 2026-08-14 | Tripuraneni Radhika Chief Medical Officer | Option exercise | +40,000 | $13.21 | $528K | 40,000 |
| 2026-08-14 | Tripuraneni Radhika Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2026-07-01 | CAIN CHRISTOPHER W. Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-07-01 | Ajer Jeffrey Robert Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-07-01 | Moses Jennifer K. Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-07-01 | Gheuens Sarah Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-07-01 | Kiselak Tomas Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-07-01 | Morris Arlene Director | Grant or award · Stock Option (Right to Buy) | +32,341 | 32,341 | ||
| 2026-05-11 | Fairmount Funds Management LLC Director | Purchase | +1,176,470 | $17.00 | $20.0M | 5,090,928 |
| 2026-03-03 | Harmon Seth Chief Financial Officer | Shares withheld for taxes | −2,031 | $30.19 | $61K | 7,850 |
| 2026-03-03 | Beetham Thomas W. Chief Operating Officer | Shares withheld for taxes | −3,048 | $30.19 | $92K | 13,361 |
| 2026-03-03 | Tousignant Jennifer Chief Legal Officer | Shares withheld for taxes | −1,675 | $30.19 | $51K | 3,494 |
| 2026-03-03 | Mahoney Stephen F. President and CEO | Shares withheld for taxes | −7,408 | $30.19 | $224K | 33,349 |
| 2026-03-03 | Tousignant Jennifer Chief Legal Officer | Option exercise | +5,169 | 5,169 | ||
| 2026-03-03 | Tousignant Jennifer Chief Legal Officer | Shares withheld for taxes | −1,724 | $29.32 | $51K | 3,445 |
| 2026-03-03 | Tousignant Jennifer Chief Legal Officer | Option exercise · Restricted Stock Units | −5,169 | 15,510 |
Page 1 of 10 · 182 trades